Monopar Therapeutics (MNPR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist

29.9400
-0.7400-2.41%

Close Dec 18 16:00 ET

158.02MMarket Cap-15.12P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here's What Could Help Monopar Therapeutics (MNPR) Maintain Its Recent Price Strength
Zacks Dec 18 07:55 ET
Monopar Therapeutics Shares Jump After First Patient Dosed in Cancer Therapy
MT NewswiresDec 6 14:57 ET
Express News | Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu
ReutersDec 5 16:21 ET
Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
GlobeNewswireDec 5 16:21 ET
Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
GlobeNewswireDec 3 08:00 ET
Express News | Monopar Therapeutics Files Prospectus Relates to Resale From Time to Time of up to 705,015 Shares of Common Stock by Selling Stockholder
ReutersNov 29 17:02 ET

Comments

Jaguar8

Yesterday 07:00

NEWS 13D

$Monopar Therapeutics (MNPR.US)$
Monopar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CHANDLER ROBINSON(19.2%),MICHAEL BROWN(17.1%), etc.

Trytosaveabit

Nov 8 07:25

Some numbers

$Monopar Therapeutics (MNPR.US)$ Results for the Third Quarter Ended September 30, 2024 Compared to the Third Quarter Ended September 30, 2023

Cash and Net Loss

Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.

Monopar project...